Is adjuvant docetaxel useful for prostate cancer?

Study examines its addition to ADT in patients without metastasis

The addition of docetaxel to ongoing treatment of men who have survived localised therapy for high-risk prostate cancer appears to confer no extra benefit, a study shows.

# Tags